A CROSS-SECTIONAL STUDY OF PATIENT-REPORTED OUTCOMES FOR BLADDER CANCER PATIENTS WITH NON-INVASIVE DISEASE
- To identify aspects of survivorship experience that differ by clinical risk (low risk
vs high risk) in patients with non-invasive bladder cancer.
- To collect and examine data on health-related quality of life (HRQOL) and symptom
- To analyze differences in outcomes between genders, stage and grade of disease, and
recency of diagnosis (new diagnosis vs ≥ 6 month diagnosis).
OUTLINE: Patients undergo a 45-minute telephone interview to assess their current medical
condition and psychological functioning (i.e., bladder cancer treatment history, levels of
depression and anxiety, quality of life, self-efficacy, and perceived social support).
Patients complete a series of questionnaires including the Lepore social constraint measure;
REACH social support measure; self-report inventories assessing patient communication,
relationship style, illness intrusiveness, fear of recurrence, and social constraint; Impact
of Events scale; Brief Symptom Index-18 and Global Severity Index; EORTC QLQ-C30 (general
health-related quality of life); and EORTC QLC-BLS24 (disease-specific health-related
quality of life).
Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
Collection and examination of data on health-related quality of life and symptom management
David M. Latini, PhD
Baylor College of Medicine
United States: Federal Government
|Dan L. Duncan Cancer Center at Baylor College of Medicine||Houston, Texas 77030|